Literature DB >> 16328283

The impact of ventrolateral thalamotomy on tremor and voluntary motor behavior in patients with Parkinson's disease.

Christian Duval1, Michel Panisset, Antonio P Strafella, Abbas F Sadikot.   

Abstract

A preferred target for parkinsonian tremor alleviation is the ventrolateral (VL) thalamus. The goal of the present study is to determine how lesions involving the presumed cerebellar and pallidal recipient areas of the "motor" thalamus would alter the tremor and motor behavior of ten patients with Parkinson's disease (PD). Tremor amplitude, power dispersion (a measure of sharpness of the power spectrum of tremor), and power distribution were quantified using a laser displacement sensor prior to, and a week after, VL thalamotomy. As well, the impact of surgery on tremor seen during movement was quantified in a manual-tracking (MT) task. Tremor-induced noise (a measure of the amount of tremor present during movement) and ERROR (difference between subject's performance and target) were quantified. Finally, bradykinesia was assessed with a rapid alternating movement (RAM) task. Duration, range, and amplitude irregularity of wrist pronation-supination cycles were computed. Both motor tasks were quantified using a highly sensitive forearm rotational sensor. Healthy age-matched control subjects were also tested. Magnetic resonance images with an integrated atlas of thalamic nuclei were used to confirm lesion location. Results show that the lesions were centered upon the posterior portion of the ventral lateral (VLp) nucleus of the thalamus, included the posterior part of the ventral lateral anterior nucleus (VLa), and extended posteriorly to encroach upon the most rostral sector of the sensory ventral posterior nucleus (VPLa). VL thalamotomy significantly decreased tremor amplitude in all cases. Power dispersion was increased significantly so that it became similar to that of control subjects. Changes in power distribution indicate that thalamotomy selectively targeted PD tremor oscillations. Tremor detected during the MT task was also markedly decreased, becoming similar to that of controls. Patients also showed significant decrease in ERROR during MT. RAM duration and range were not significantly modified by the surgery, and patients' performance remained impaired compared to healthy control subjects. Collectively, these results suggest that lesions involving the presumed "cerebellar" and "pallidal" recipient sectors of the motor thalamus do not worsen bradykinesia, suggesting that neural circuits other than the pallido-thalamo-cortical loop may be involved in slowness of movement in PD. A review of alternate pathways is presented.

Entities:  

Mesh:

Year:  2005        PMID: 16328283     DOI: 10.1007/s00221-005-0198-4

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  62 in total

Review 1.  Primate anterior cingulate cortex: where motor control, drive and cognition interface.

Authors:  T Paus
Journal:  Nat Rev Neurosci       Date:  2001-06       Impact factor: 34.870

2.  The detection of tremor during slow alternating movements performed by patients with early Parkinson's disease.

Authors:  Christian Duval; Abbas F Sadikot; Michel Panisset
Journal:  Exp Brain Res       Date:  2003-12-10       Impact factor: 1.972

3.  Cerebral blood flow changes induced by subthalamic stimulation in Parkinson's disease.

Authors:  Antonio P Strafella; Alain Dagher; Abbas F Sadikot
Journal:  Neurology       Date:  2003-03-25       Impact factor: 9.910

Review 4.  The contribution of basal forebrain to limbic-motor integration and the mediation of motivation to action.

Authors:  G J Mogenson; C R Yang
Journal:  Adv Exp Med Biol       Date:  1991       Impact factor: 2.622

5.  Excitotoxic lesions of the pedunculopontine tegmental nucleus produce contralateral hemiparkinsonism in the monkey.

Authors:  J Kojima; Y Yamaji; M Matsumura; A Nambu; M Inase; H Tokuno; M Takada; H Imai
Journal:  Neurosci Lett       Date:  1997-04-25       Impact factor: 3.046

6.  The role of the ballistocardiac impulse in the genesis of physiological tremor.

Authors:  C D Marsden; J C Meadows; G W Lange; R S Watson
Journal:  Brain       Date:  1969       Impact factor: 13.501

7.  Optimal location of thalamotomy lesions for tremor associated with Parkinson disease: a probabilistic analysis based on postoperative magnetic resonance imaging and an integrated digital atlas.

Authors:  Jeffrey D Atkinson; D Louis Collins; Gilles Bertrand; Terry M Peters; G Bruce Pike; Abbas F Sadikot
Journal:  J Neurosurg       Date:  2002-05       Impact factor: 5.115

8.  Indications for surgical treatment of Parkinson's disease after levodopa therapy.

Authors:  J van Manen; J D Speelman; R J Tans
Journal:  Clin Neurol Neurosurg       Date:  1984       Impact factor: 1.876

9.  Plastic change of thalamic organization in patients with tremor after stroke.

Authors:  C Ohye; T Shibazaki; T Hirai; Y Kawashima; M Hirato; M Matsumura
Journal:  Appl Neurophysiol       Date:  1985

10.  The impact of ventrolateral thalamotomy on high-frequency components of tremor.

Authors:  Christian Duval; Antonio P Strafella; Abbas F Sadikot
Journal:  Clin Neurophysiol       Date:  2005-03-28       Impact factor: 3.708

View more
  16 in total

1.  Paradoxical Motor Recovery From a First Stroke After Induction of a Second Stroke: Reopening a Postischemic Sensitive Period.

Authors:  Steven R Zeiler; Robert Hubbard; Ellen M Gibson; Tony Zheng; Kwan Ng; Richard O'Brien; John W Krakauer
Journal:  Neurorehabil Neural Repair       Date:  2015-12-31       Impact factor: 3.919

2.  The influence of levodopa-induced dyskinesias on manual tracking in patients with Parkinson's disease.

Authors:  Sarah Lemieux; Mehrdad Ghassemi; Mandar Jog; Roderick Edwards; Christian Duval
Journal:  Exp Brain Res       Date:  2006-08-30       Impact factor: 1.972

3.  Quantifying the importance of high frequency components on the amplitude of physiological tremor.

Authors:  Benoit Carignan; Jean-François Daneault; Christian Duval
Journal:  Exp Brain Res       Date:  2009-12-29       Impact factor: 1.972

4.  The evolutionary origin of the vertebrate basal ganglia and its role in action selection.

Authors:  Sten Grillner; Brita Robertson; Marcus Stephenson-Jones
Journal:  J Physiol       Date:  2013-01-14       Impact factor: 5.182

5.  Multi-contrast unbiased MRI atlas of a Parkinson's disease population.

Authors:  Yiming Xiao; Vladimir Fonov; Silvain Bériault; Fahd Al Subaie; M Mallar Chakravarty; Abbas F Sadikot; G Bruce Pike; D Louis Collins
Journal:  Int J Comput Assist Radiol Surg       Date:  2014-05-20       Impact factor: 2.924

6.  Targeted activation of midbrain neurons restores locomotor function in mouse models of parkinsonism.

Authors:  Débora Masini; Ole Kiehn
Journal:  Nat Commun       Date:  2022-01-26       Impact factor: 14.919

7.  Vasoactive intestinal peptide (VIP) treatment of Parkinsonian rats increases thalamic gamma-aminobutyric acid (GABA) levels and alters the release of nerve growth factor (NGF) by mast cells.

Authors:  Orhan Tansel Korkmaz; Neşe Tunçel; Muzaffer Tunçel; Elif Mine Oncü; Varol Sahintürk; Mustafa Celik
Journal:  J Mol Neurosci       Date:  2009-12-02       Impact factor: 3.444

8.  Patch-based label fusion segmentation of brainstem structures with dual-contrast MRI for Parkinson's disease.

Authors:  Yiming Xiao; Vladimir S Fonov; Silvain Beriault; Ian Gerard; Abbas F Sadikot; G Bruce Pike; D Louis Collins
Journal:  Int J Comput Assist Radiol Surg       Date:  2014-09-24       Impact factor: 2.924

9.  The amplitude of physiological tremor can be voluntarily modulated.

Authors:  Benoit Carignan; Jean-François Daneault; Christian Duval
Journal:  Exp Brain Res       Date:  2009-01-24       Impact factor: 1.972

10.  Using a smart phone as a standalone platform for detection and monitoring of pathological tremors.

Authors:  Jean-François Daneault; Benoit Carignan; Carl Éric Codère; Abbas F Sadikot; Christian Duval
Journal:  Front Hum Neurosci       Date:  2013-01-18       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.